2010年欧洲呼吸学会和欧洲胸外科学会恶性胸膜间皮瘤诊疗指南简介
被引量:1
摘要
恶性胸膜间皮瘤是一种罕见疾病,且为一种预后很差的肿瘤,但其发病率逐年上升。欧洲呼吸学会和欧洲胸外科学会特别工作组于2010年正式颁布了欧洲呼吸学会和欧洲胸外科学会恶性胸膜间皮瘤诊疗指南。今将指南简介如下。读者如要仔细研究指南,请参阅欧洲呼吸杂志刊登的全文。
出处
《国际呼吸杂志》
2010年第10期577-580,共4页
International Journal of Respiration
参考文献1
-
1A. Scherpereel,P. Astoul,P. Baas,T. Berghmans,H. Clayson,P. de Vuyst,H. Dienemann,F. Galateau-Salle,C. Hennequin,G. Hillerdal,C. Le Pe'choux,L. Mutti,J-C. Pairon,R. Stahel,P. van Houtte,J. van Meerbeeck,D. Waller,W. Weder,宋作庆,徐萧洪.欧洲呼吸学会和欧洲胸外科医师学会恶性胸膜间皮瘤诊疗指南[J].中国肺癌杂志,2010(10):999-1021. 被引量:57
二级参考文献100
-
1Bottomley A, Coens C, Efficace F, et al. Symptoms and patientreported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTCNCIC08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.J Clin Oncol,2007; 25: 5770-5776.
-
2Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion.Chest 1995; 107: 1454-1456.
-
3Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma:results of surgery. EurJ Cardiothorac Surg 1997; 11: 210-213.
-
4Halstead JC, Lim E, Venkateswaran RM, et al. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 2005; 31: 314-320.
-
5Nakas A, Martin Ucar AE, Edwards JG, et al. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33: 83-88.
-
6Martin-Ucar AE, Edwards JG, Rengajaran A, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. EurJ Cardiothorac Surg 2001; 20:1117-1121.
-
7Dogan AUp Baris YI, Dogan M, et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006; 66: 5063-5068.
-
8Lin RT, Takahashi K, Karjalainen A, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 2007; 369: 844-849.
-
9Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-1603.
-
10Segura O, Burdorf A, Looman C, Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003; 60: 50-55.
共引文献56
-
1冷雪峰,韩泳涛.恶性胸膜间皮瘤:刀尖上的生存[J].中华胸部外科电子杂志,2022,9(4):208-211.
-
2韩丹.VEGF与恶性胸膜间皮瘤的研究进展[J].昆明医科大学学报,2013,34(7):1-3.
-
3陈洁,赵微,刘星辰,田庆,杨震,陈良安.恶性胸膜间皮瘤45例临床分析[J].中国肺癌杂志,2012,15(2):97-102. 被引量:9
-
4施林妹,杨文兰,陶巨蔚.超声检查在胸膜间皮瘤诊断中的应用[J].临床肺科杂志,2012,17(6):1090-1091.
-
5冯起校.恶性胸腔积液的诊治进展[J].职业与健康,2012,28(10):1269-1272. 被引量:4
-
6刘国荣,程春虹,魏华寿.胸腔积液及血清C-反应蛋白联合检测在恶性胸腔积液诊断中的价值[J].中国当代医药,2012,19(16):98-99. 被引量:3
-
7冯明军,张玉霞,那志敏.睾丸腱鞘恶性间皮瘤胸腹膜转移1例[J].牡丹江医学院学报,2012,33(4):61-62.
-
8杜春玲,刘玉全,魏娜,罗国仕.恶性胸膜间皮瘤15例临床分析[J].临床内科杂志,2012,29(11):747-749.
-
9朱旭贞,马安,王越.多发脑裂头蚴病一例报告[J].现代实用医学,2012,24(11):1313-1313.
-
10阮雅君,潘登,夏朝霞.胸水细胞块鉴别肺及胸膜恶性肿瘤中免疫组织化学抗体的选择[J].实用肿瘤杂志,2013,28(3):292-294. 被引量:4
同被引文献17
-
1Zucali PA, De Vincenzo F, Simonelli M, et al. Future develop- ments in the management of malignant pleural mesothelioma [ J ]. Expert Rev Anticancer Ther, 2009,9(4) :453-467.
-
2Chen SE, Pace MB. Malignant pleural mesothelioma [ J ]. Am J Health Syst Pharm, 2012,69 (5) :377-385.
-
3Oken MM, Creech RH, Tormey DC, et al. Toxicity and Response Criteria of the Eastern Cooperative Oncology Group[ J]. Am J Clin Oncol, 1982,5:649-655.
-
4Kent M, Rice D, Flores R. Diagnosis, staging, and surgical treat- ment of malignant pleural mesothelioma[J]. Curr Treat Options On- col,2008,9 ( 2-3 ) : 158-170.
-
5Robinson BW, Lake RA. Advances in malignant mesothelioma[ J]. N Engl J Med, 2005,353:1591-1603.
-
6Campbell NP, Kindler HL. Update on Malignant Pleural Mesothelio- ma[J]. Semin Respir Crit Care Med,2011,32( 1 ) :102-110.
-
7Robinson BW, Musk AW, Lake RA. Malignant mesothelioma[J]. Lancet, 2005,366:397-408.
-
8Otsuka H, Terazawa K, Morita N, et al. Is FDG-PET/CT useful for managing malignant pleural mesothelioma [ J ]. J Med Invest, 2009, 56(1-2) :16-20.
-
9Yildirim H, Metintas M, Entok E, et al. Clinical value of fluorode- oxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related be- nign pleural disease: an observationl pilot study [ J ]. J Thorac On- col, 2009,4(12) :1480-1484.
-
10Husain AN,Colby TV, Ordonez NG, et al. Guidelines for patholog- ic diagnosis of malignant: a consensus statement from the Interna- tional Mesothelioma Interest Group [ J ]. Arch Pathol Lab Med, 2009,133(8) :1317-1331.
-
1王建旗,刘杰,傅研,胡大一.2001年欧洲慢性心力衰竭诊治指南概要[J].中国医药导刊,2002,4(2):79-88. 被引量:12
-
2席亮(编译).防治慢性心力衰竭的最新指导原则出台[J].中国处方药,2005(10):48-48.
-
3杨萍,方昊,郭钦瑞.诸暨市1993年-2002年麻疹流行病学分析[J].传染病信息,2004,17(1):46-47. 被引量:3
-
4诊断1型糖尿病患者的干预研究指南[J].继续医学教育,2005,19(1):20-23.
-
5美国糖尿病协会免疫学工作组,童玉.新诊断1型糖尿病患者的干预研究指南[J].中国糖尿病杂志,2003,11(3):225-227.
-
6《抗癌新药研究指南》已出版[J].中国药物化学杂志,2010,20(1):10-10.
-
7于畅洋.青少年肥胖者2型糖尿病及高危因素的研究[J].糖尿病新世界,2016,0(1):193-195. 被引量:2
-
82012年第二届亚太地区幽门螺杆菌会议[J].胃肠病学,2011,16(10):636-636.
-
9全球规模最大的糖尿病临床研究证实预混胰岛素类似物可全面控制血糖[J].糖尿病天地,2008(11):74-74.
-
10姚瑜.美国预防服务特别工作组推荐的衣原体感染筛查指南概要[J].国外医药(抗生素分册),2008,29(4):163-163.